AXERT^ tablets are indicated for the acute treatment of migraine
with or without aura in adults. AXERT^ tablets are indicated for
the acute treatment of migraine headache pain in adolescents age 12 to
17 years with a history of migraine attacks with or without aura
usually lasting 4 hours or more (when untreated). In adolescents age
12-17 years, efficacy of AXERT^ on migraine associated symptoms
(nausea, photophobia and phonophobia) was not established. AXERT^ is not intended for the prophylactic therapy of migraine or
for use in the management of hemiplegic or basilar migraine. Safety
and effectiveness of AXERT^ have not been established for cluster
headache which is present in an older, predominantly male population. AXERT^ is a prescription medication for the acute treatment of
migraine with or without aura in adults, and for the acute treatment
of migraine headache pain in adolescents age 12 to 17 years with a
history of migraine attacks with or without aura usually lasting 4
hours or more (when untreated). If you have no response for the first
migraine attack treated with AXERT^, then your doctor will need to
see if you really have migraine before you take AXERT^ to treat
any future attacks. You should not take AXERT^ if you have heart
disease, uncontrolled high blood pressure or have ever had heart
disease. If you have risk factors for heart disease (high blood
pressure, high cholesterol, diabetes, obesity, smoking, family history
of heart attack, menopause, or are a male over 40 years of age), or if
you are pregnant, nursing, or thinking about becoming pregnant, talk
with your doctor before taking AXERT^. You should also tell your
doctor if you have had a stroke of any type or any transient ischemic
attacks, or if you have circulation (blood flow) problems, as you
should not use AXERT^. Contact your doctor immediately if you are
experiencing symptoms of pain, tightness, pressure, or heaviness in
your chest, throat, neck, or jaw, shortness of breath, weakness, or
slurring of speech, if you experience abdominal pain or bloody
diarrhea, or if your fingers or toes become cold or discolored. In
very rare cases, serious heart problems have occurred in patients
without known heart disease. AXERT^, like other triptans, may be associated with a potentially
life-threatening condition mainly when taken together with selective
serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine
reuptake inhibitors (SNRIs), two classes of drugs for depression or
other disorders. Common SSRIs are Celexa^ (citalopram HBr),
Lexapro^ (escitalopram oxalate), Paxil^ (paroxetine),
Prozac^/Sarafem^ (fluoxetine), Symbyax^
(olanzapine/fluoxetine), Zoloft^ (sertraline), and Luvox^
(fluvoxamine). Common SNRIs are Cymbalta^ (duloxetine) and
Effexor^ (venlafaxine). If you experience symptoms such as
confusion, sweating, flushing, rapid heartbeat, diarrhea, muscle
weakness, poor balance, or worsening headache, contact your doctor
immediately. Tell your doctor about all prescription and over-the-counter
medications you are taking. Do not take AXERT^ if you have taken
an ergotamine-containing or ergot-type medication or another triptan
in the last 24 hours. Do not take if you have had an allergic reaction
to AXERT^ or any of its ingredients. Tell your doctor if you have
had an allergic reaction to a sulfonamide drug or if you are taking
ketoconazole. The most common AXERT^ side effects in adults are nausea,
sleepiness, tingling sensation, headache, and dry mouth. The most common AXERT^ side effects in adolescents are dizziness,
sleepiness, headache, tingling sensation, nausea and vomiting. Ask your doctor about side effects, possible drug interactions, and
any other important questions you may have before taking AXERT^. Celexa and Lexapro are registered trademarks of Forest Laboratories. Paxil is a registered trademark of GlaxoSmithKline order provigil. Symbyax,
Prozac/Sarafem and Cymbalta are registered trademarks of Eli Lilly. Zoloft is a registered trademark of Pfizer. Luvox is a registered
trademark of Solvay. Effexor is a registered trademark of Wyeth. You are encouraged to report negative side effects of prescription
drugs to the FDA. Visit, or call 1-800-FDA-1088. For full U. S. Prescribing
Information,. YJanssen Pharmaceuticals, Inc. 2010. All rights
reserved. Licensed from
Your use of the information on this site is

subject to the terms of our Please see our. publishes this site and is
solely responsible for its contents. This site is intended for the use of our customers, patients, healthcare professionals, and residents in the United States. Janssen Pharmaceuticals, Inc. recognizes that the
Internet is a global communications medium; however, laws, regulatory
requirements and medical practices for pharmaceutical products vary
from country to country. The prescribing information included here may
not be appropriate for use outside the United States and Puerto Rico. Capitalized product names are trademarks of Janssen
Pharmaceuticals, Inc. This page was last updated on Dec 07 2010 at 00:32:34 GMT-05:00.